Table 2.
Altered Pathways | REF | HP 13C MRS | ||||
---|---|---|---|---|---|---|
HP Probe | Sequences | Use | REF | |||
Low-grade mutant IDH1 glioma |
|
10, 42, 56–58, 79 |
[1-13C]-α-KG T1~52s at 9.4T Php~16% |
|
|
62, 78,79 |
[1-13C]-pyruvate T1~67s at 3T Php~14–40% |
|
|
69, 57 | |||
[2-13C]-pyruvate T1~40s at 3T Php~27% |
|
|
30, 77 | |||
[1-13C]-ethyl
pyruvate T1~45s at 3T Php~28–35% |
|
81 | ||||
[U-13C]-α-KB T1~52s at 3T Php~10% |
|
82 | ||||
|
59 |
[1-13C]-dihydroascorbate T1~57s at 3T Php ~6–8% |
|
88, 89 | ||
|
43, 53–55 |
[2-13C,
1,22H4]-choline
chloride T1~60s at 3T Php~28–35% |
|
101–103 | ||
|
98–100 |
[1,4-13C2]-fumarate T1~24s at 9.4T Php ~26–35% |
|
98–100 |